News

Ochsner Health has reached a significant milestone: performing more than 50,000 minimally invasive robot-assisted surgeries ...
International medical graduates are underrepresented in leadership roles at NCI-designated cancer centers, according to study ...
June brought major breast cancer updates, and CURE is sharing the latest treatment combinations, biomarker-driven care and ...
Registration has opened for JADPRO Live 2025, the premier educational conference for oncology advanced practitioners. It will ...
City of Hope’s Dr. Yuman Fong has surgically cured cancers once thought to be incurable and is advancing AI and robotic ...
Dr. Rita Mukhtar sits down for a conversation with Dr. Joshua Sabari to discuss the potential use of ctDNA to guide breast ...
In an interview with Targeted OncologyTM, Ravi Muvner, MD, urologist at Hackensack University Medical Center, discusses how targeted therapies have changed the landscape of prostate cancer treatment.
The Food and Drug Administration (FDA) has approved Zusduri (mitomycin intravesical solution) for adults with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (NMIBC).
Some heat safety tips are obvious — but some are surprising. Know how much water to drink and why humidity actually matters.
As early-onset cancer diagnoses surge among young people, doctors and researchers are urgently exploring potential causes ...
The Supreme Court on Friday granted a partial stay of nationwide injunctions issued by district courts against President ...
Esophageal adenocarcinoma (EAC), one of two major forms of esophageal cancer, is the sixth most deadly cancer worldwide for ...